Conexeu Sciences is trading at $3.15, down 5.12%; available evidence has not established a specific cause for the decline. - No company announcement or clear company-specific catalyst was identified on October 2, 2026. - The latest scheduled event is participation in an investor conference running October 1–3. - Major indexes were higher, while the stock’s recent losses continued.